36 Investor Meetings and No Lead: How a Vertical SaaS Seed Round Got Two Term Sheets From 12 Meetings

The founder was not short of meetings. Over four months, he had spoken to 36 investors about his vertical SaaS company, which sells workflow and billing software to multi-location diagnostic labs. ARR was ₹2.4 Cr, net revenue retention was healthy, and customers were mid-sized lab chains with real budgets. He was raising ₹6 Cr.

Thirty-six conversations produced warm feedback, a few follow-up calls and no lead investor. By the time he came to us, he had about seven months of runway and was considering a smaller bridge from existing angels.

What 36 meetings actually were

The first thing we did was put every one of the 36 conversations into a table and ask one question of each: could this investor, at this moment, lead a ₹6 Cr seed round in vertical SaaS?

Five of 36. That was the real pipeline. The other 31 were not bad investors. They were the wrong investors for this round:

• Large multi-stage funds (11 meetings). One ran an active seed programme and was a real candidate. Most of the rest write first cheques of ₹25 Cr and above, or do seed only very selectively when a partner has a strong personal conviction. They took meetings to track the company for a later round, which is useful, but they were never going to lead a ₹6 Cr seed.
• Angels and angel networks (9 meetings). Valuable participants, but at seed most angel groups follow a lead's price and terms rather than set them. Since SEBI's 2025 angel fund framework, structured angel funds can only take money from accredited investors and have their own process. See SEBI's angel fund rules.
• Family offices (5 meetings). Several liked the business. None had a team that could run seed diligence on a SaaS company and set terms. Family offices are often excellent co-investors, as we cover in family office vs VC vs strategic investor.
• Corporate VCs (4 meetings). One healthcare-focused corporate fund was a real fit. Two had portfolio companies selling into the same labs, which would have made them conflicted.

Of the seven seed funds that do lead rounds, four had a problem the founder did not know about: one had just made a similar investment, one was at the end of its investment period and deploying only into follow-ons, and two had not done a B2B deal in the previous 18 months.

The five-filter screen we use before any meeting

India has no shortage of investors. Inc42 counted more than 1,100 active investors backing Indian startups in H1 2026 alone. The problem is the opposite: too many names and too little information about who can lead what. Seed funding is also tighter than it looks. Tracxn put seed-stage funding in India at $1.1 Bn in 2025, down 30% from 2024, and Inc42 noted a slight decline in the number of seed deals in H1 2026 even as total seed dollars rose. Fewer leads, writing more carefully.

So we screened about 140 names against five filters before the founder took a single new meeting.

The 12 that came out the other end were the tier 1 list. We added four corporate and strategic funds as tier 2, for later in the process, and six angels and family offices as tier 3, to be invited once a lead was in sight.

Sequencing: leads first, then everyone else

The second change was the order. In the first four months, the founder had taken meetings as introductions arrived: a family office one week, a large fund the next, an angel network the week after. Each meeting was separate, and no investor felt any urgency.

We ran it differently:

1. Weeks 1 and 2: preparation. One deck, one financial model, one data room, ready before the first new meeting. The data room problems investors find in week two were fixed in advance.
2. Weeks 3 to 5: tier 1 leads in parallel. All 12 first meetings were booked inside a three-week window, so second meetings overlapped and partners heard from each other's market that the company was in process.
3. Weeks 6 and 7: partner meetings and term sheets. Tier 2 strategic funds were brought in once two leads were in partner discussions.
4. Weeks 8 to 10: fill the round. Tier 3 angels and family offices joined at the lead's price.

The conversion from first meeting to second meeting went from 25% to 58%. That is not because the founder pitched better. It is because the investors in the room could actually do the deal.

What the long sales cycle changed

One more filter mattered more than the founder expected. Vertical SaaS sold to diagnostic lab chains has a 4 to 6 month sales cycle and annual contracts. Investors used to product-led SaaS, where a free trial converts in weeks, read slow quarter-on-quarter new logo growth as weakness. Investors who had backed healthcare IT or enterprise workflow companies read the same numbers as normal and focused on what they cared about: contract value, retention and the size of the pipeline.

So we rebuilt the metrics slide around pipeline coverage: qualified pipeline worth about 3.2 times the next two quarters' new ARR target, with stage-by-stage conversion from the last four quarters. The right investors could underwrite that. The wrong ones never would have.

The outcome

Within seven weeks of starting the reset, the company had two term sheets from tier 1 leads. It closed ₹6 Cr with a seed fund leading ₹4 Cr, the healthcare-focused corporate fund from tier 2 taking ₹1 Cr, and angels filling the rest.

How to build a lead investor list that works

• Start with a long list, then screen hard. Public databases, recent funding announcements and portfolio pages are enough to apply the five filters.
• Ask every investor, early and directly: "Do you lead rounds of this size, and from which fund?" Most will tell you.
• Separate leads, strategic investors and participants. Different jobs, different timing.
• Book lead meetings into a tight window. The case on the round that had no competitive tension shows what happens when you don't.
• Keep a meeting log with each investor's objection in their own words. If a raise stalls anyway, that log is how you diagnose it, as in the nine-month failed raise.

Sources

• Inc42: Indian startup funding slips 9% to $5.2 Bn in H1 2026
• People Matters: Tech startup funding falls 17% to $10.5 Bn in 2025, Tracxn report